Medical device maker DiFusion Inc. has received $5.2 million of a planned $16 million financing.
The Georgetown-based company collected the capital from 54 investors, according to a Friday filing with the U.S. Securities and Exchange Commission .
DiFusion, which was founded in 2008, is working on a new product designed to prevent postoperative infections.
In May 2011, the company, which had been based in Austin, signed a multi-year lease with the The Texas Life-Science Collaboration Center in Georgetown. The TLCC, about 30 minutes north of Austin, is a nonprofit accelerator that provides mentoring and other incubation services geared toward life sciences, as well as biotech infrastructure such as wet labs. The complex was built through a collaboration with local universities and colleges and with input from health care organizations.
